Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus

被引:83
|
作者
Henkel, E [1 ]
Menschikowski, M
Koehler, C
Leonhardt, W
Hanefeld, M
机构
[1] Tech Univ Dresden, Ctr Clin Studies Metab & Endocrinol, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Inst Klin Chem & Labormed, Fac Med CG Carus, D-01307 Dresden, Germany
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2005年 / 54卷 / 09期
关键词
D O I
10.1016/j.metabol.2005.03.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucagon is the physiological antagonist of insulin. Postprandial (pp) hyperglycemia in impaired glucose tolerance (IGT) and in type 2 diabetes mellitus (T2DM) may also depend on irregularities in glucagon secretion. This study investigated the glucagon excursion after a lip id-glucose-protein tolerance test in subjects with different stages of glucose intolerance. We also analyzed the relationship between pp glucagon secretion and hyperglycemias. A total of 64 men (27 healthy subjects with normal glucose tolerance [NGT], 15 with IGT, and 22 with T2DM) were examined. Plasma glucose (PG), insulin, proinsulin, free fatty acids, and triglycerides were measured in the fasting state and at 30 minutes and 2, 3, 4, and 6 hours after the intake of the test meal, which contained 126 g carbohydrates, 92 g fat, and 17 g protein. Postprandial concentrations of metabolic parameters were calculated as area under the curve (AUC). Glucagon was measured in the fasting state and at 30 minutes and 2 and 4 hours pp. Early glucagon increment was defined as glucagon at 30 minutes minus fasting glucagon. The insulin response was quantified as insulin increment divided by PG increment in the corresponding time. Insulin resistance was calculated using homeostasis model assessment (HOMA). Fasting glucagon was significantly increased in IGT vs NGT (P <.05), and early glucagon increment was significantly higher in T2DM vs NGT and IGT (P <.05). The 2-hour glucagon concentration after the load (AUC) was increased in IGT and T2DM vs NGT (P <.05). Early glucagon increment and the 2-hour AUC of glucagon were strongly correlated to pp glycemia (r = 0.494 and P =.001, and r = 0.439 and P =.003, respectively). An inverse correlation was observed between early glucagon increment and insulin response at 30 minutes and 2 hours after the meal load (r = -0.287 and P =.026, and r = -0.435 and P =.001, respectively). The 2-hour AUC of glucagon was significantly associated with insulin resistance (r = 0.354, P =.020). Multivariate analysis revealed 2-hour insulin response and early glucagon increment as significant independent determinants of the AUC of PG in IGT (R 0.787). In T2DM, 2-hour insulin response, insulin resistance, and early glucagon increment were significant determinants of the AUC of PG (R = 0.867). Our study suggests an important role for the irregularities in glucagon response in the pp glucose excursion after a standardized oral mixed meal in IGT and in T2DM. According to our data, a bihormonal imbalance starts before diabetes is diagnosed. Prospective studies are needed to evaluate the impact of glucagon on the progression of glucose intolerance and the possible effects of medicinal suppression of glucagon increment to prevent the progression of glucose tolerance. (c) 2005 Elsevier Inc. All rights reserved.
引用
下载
收藏
页码:1168 / 1173
页数:6
相关论文
共 50 条
  • [41] Plasma glucagon levels measured by sandwich ELISA are correlated with impaired glucose tolerance in type 2 diabetes
    Kobayashi, Masaki
    Satoh, Hiroaki
    Matsuo, Toshihiro
    Kusunoki, Yoshiki
    Tokushima, Masahiko
    Watada, Hirotaka
    Namba, Mitsuyoshi
    Kitamura, Tadahiro
    ENDOCRINE JOURNAL, 2020, 67 (09) : 903 - 922
  • [42] Glucagon response to hyperglycemia following islet cell transplantation in type 1 diabetes mellitus
    Alejandro, Rodolfo
    Lagari, Violet
    Baidal, David
    Messinger-Cayetano, Shari
    Ricordi, Camillo
    Mendez, Armando
    XENOTRANSPLANTATION, 2009, 16 (05) : 313 - 313
  • [43] Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus
    Prior, JO
    Quiñones, MJ
    Hernandez-Pampaloni, M
    Facta, AD
    Schindler, TH
    Sayre, JW
    Hsueh, WA
    Schelbert, HR
    CIRCULATION, 2005, 111 (18) : 2291 - 2298
  • [44] Autonomic Neuropathy and Endothelial Dysfunction in Patients With Impaired Glucose Tolerance or Type 2 Diabetes Mellitus
    Tiftikcioglu, Bedile Irem
    Bilgin, Sule
    Duksal, Tarik
    Kose, Sukran
    Zorlu, Yasar
    MEDICINE, 2016, 95 (14)
  • [45] Predictors of angiopathy in patients with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus
    Romanenko, I. A.
    Polyatykina, S.
    Tomilova, I. K.
    Grinshteyn, V. B.
    Akayzin, E. S.
    DIABETES MELLITUS, 2005, 8 (02): : 27 - 30
  • [46] Type 2 diabetes mellitus, impaired glucose tolerance and associated factors in a rural Palestinian village
    Husseini, A
    Abdul-Rahim, H
    Awartani, F
    Giacaman, R
    Jervell, J
    Bjertness, E
    DIABETIC MEDICINE, 2000, 17 (10) : 746 - 748
  • [47] Prevalence of Type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent
    Zargar, AH
    Khan, AK
    Masoodi, SR
    Laway, BA
    Wani, AI
    Bashir, MI
    Dar, FA
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 47 (02) : 135 - 146
  • [48] Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus
    Delorme, S
    Chiasson, JL
    CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (02) : 184 - 189
  • [49] Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in obese Argentinean children and adolescents
    Mazza, CS
    Ozuna, B
    Krochik, AG
    Araujo, MB
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2005, 18 (05): : 491 - 498
  • [50] Clinical and metabolic phenotype of obese children and adolescents with normal glucose tolerance, impaired glucose tolerance and type 2 diabetes mellitus
    Ugrasbul, Figen
    Broussard, Julia R.
    Sherman, Ashley K.
    Babar, Ghufran S.
    HORMONE RESEARCH, 2009, 72 : 334 - 334